Kevin Rakin
Kevin Rakin's purchase track record
Kevin Rakin has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/30/2026 | ELUT | $74K | -3.8% | -18.4% | +7.9% |
| 12/17/2025 | ELUT | $26K | +113.9% | +96.2% | +10.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
QSI impacted by regional tensions in Gulf markets. Saudi and Gulf stocks recently declined after the Houthis claimed attacks on Riyadh. This regional instability may affect sentiment for Quantum-Si Incorporated, which operates in the Middle East. The stock is currently trading within its 52-week range, with technical indicators showing a breakout signal.
Transaction History
| ELUT | ▼ Sell | Gift | 70,000 | $0 | 6/1/2026 | View on chart |
| ELUT | ▼ Sell | Other | 50,000 | $0 | 6/1/2026 | View on chart |
| ELUT | ▲ Buy | Open Market | 70,000 | $74K | 1/30/2026 | View on chart |
| ELUT | ▲ Buy | Open Market | 50,000 | $26K | 12/17/2025 | View on chart |
| ELUT | ▼ Sell | Other | 4,372,497 | — | 12/11/2025 | View on chart |
| QSI | ▼ Sell | Other | 601,000 | $0 | 12/20/2022 | View on chart |
| QSI | ▼ Sell | Open Market | 89,000 | $191K | 12/15/2022 | View on chart |
| ORMP | ▼ Sell | Open Market | 10,000 | $94K | 3/21/2022 | View on chart |
| ORMP | ▲ Buy | Option Exercise | 6,667 | $32K | 2/17/2022 | View on chart |
| ORMP | ▼ Sell | Tax Withholding | 3,010 | $32K | 2/17/2022 | View on chart |
| ORMP | ▼ Sell | Gift | 5,000 | $0 | 2/11/2022 | View on chart |
| ORMP | ▲ Buy | Grant | 6,000 | — | 1/3/2022 | View on chart |
| ORMP | ▼ Sell | Gift | 5,000 | $0 | 12/16/2021 | View on chart |
| ORMP | ▼ Sell | Open Market | 21,100 | $443K | 9/16/2021 | View on chart |
| ORMP | ▲ Buy | Grant | 10,000 | — | 8/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Elutia Secures $8M from Boston Scientific, Funds Through 2029
Elutia announced it received an $8 million payment from Boston Scientific. This funding ensures the company is fully capitalized through 2029, removing near-term financial uncertainty. The news provides significant context for the stock's recent price action, as the company now has a clear runway for operations without immediate capital needs.
Elutia Secures $8M from Boston Scientific, Funds Through 2029. Elutia announced it received an $8 million payment from Boston Scientific. This funding ensures the company is fully capitalized through 2029, removing near-term financial uncertainty. The news provides significant context for the stock's recent price action, as the company now has a clear runway for operations without immediate capital needs.